Very-low-dose decitabine and rhTPO for thrombocytopenia in lower-risk myelodysplastic syndrome.

Ann Hematol · 2026 · PMC13095902 · PMID 42009831

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

A study combining AZA and eltrombopag in higher-risk MDS did not reduce platelet transfusions and showed a trend toward AML progression [ 33 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.